ADVFN - Advanced Financial Network.
HOME» NYSE » C » CVS Stock Price » CVS Stock News

Cvs Share News

 Cvs Caremark Corp. Stock Price
CVS Stock Price
 Cvs Caremark Corp. Stock Chart
CVS Stock Chart
 Cvs Caremark Corp. Stock News
CVS Stock News
 Cvs Caremark Corp. Company Information
CVS Company Information
 Cvs Caremark Corp. Stock Trades
CVS Stock Trades

Lyrical Asset Charges Performance Fee Only When It Outperforms

By Amy Or Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Lyrical Asset Management is among a rare breed that charges hedge fund-like fees for a long-only fund. But unlike Lyrical's counterparts in the hedge world that charge a 2% management fee and take a 20% cut of any gains, Lyrical's management fee is 0.75% and it takes a 20% performance fee only when its gains exceed benchmarks such as the Standard & Poor's 500-stock index, or the Russell 1000 index. "We think it's a fair structure...and a respectful aligning of interests," said Lyrical co-founder Jeffrey Keswin. Keswin was co-founder and co-president of Greenlight Capital Inc. alongside famed short-seller and value investor David Einhorn. Keswin left Greenlight in 2002 and in 2004 founded Lyrical Partners, a multi-capability investment-management platform of which Lyrical Asset Management is part. "Fundamentally, we are betting on our ability to perform and, in fact, to outperform over time," he said. And outperform Lyrical has. Its $360 million U.S. Value Equity strategy gained a net 68.4% in 2009 and 22.3% in 2010, according to data provider eVestment, 49 percentage points above the S&P 500 for those two years. The fund declined by 1.2% last year when the S&P was up 2.1% including dividends, but it was up 13.2% in the first quarter compared with the S&P's 12.6% rally. Lyrical's strategy couldn't be simpler: Invest an equal amount in 35 large- and mid-capitalization stocks and hold them until they reach the target price Lyrical has set for each of them. Since the portfolio is very concentrated, the fund pays special attention to the quality of stocks it buys. "We only invest in tangible businesses that we can thoroughly analyze and understand," said Lyrical's other co-founder and managing partner, Andrew Wellington. "You won't find us owning Goldman Sachs [Group Inc.] (GS) or Bank of America [Corp.] (BAC), not because we think they are bad stocks, but because they are too opaque and complex to properly analyze." The portfolio consists of a variety of names in many sectors, including drug-store chain CVS Caremark Corp. (CVS), cable-system giant Comcast Corp. (CMCSA), computer maker Dell Inc. (DELL) and Goodyear Tire & Rubber co. (GT). In financial services, Lyrical holds insurer Aetna Inc. (AET) and Ameriprise Financial Inc. (AMP), believing the latter's asset-management business was underpriced by many who focused only on the insurance operations. Contrary to a market view that one has to trade often to take advantage of market volatility, Lyrical averages just five buys and five sells a year. Wellington, who ran a five-star mutual fund of Neuberger Berman Group LLC between 2002 and 2005, said his investment discipline is to remain unfazed by market volatility. "Short-term market movements are random. Our goal is maximize long-term performance, so we don't let the day-to-day fluctuations of the market distract us from that goal," he said. Last month, the fund got out of National Fuel Gas Co. (NFG) and added specialty-chemical company Celanese Corp. (CE) at less than $45 a share. Wellington said he expects Celanese's sales to grow faster than global gross domestic product due to its exposure to faster-growing geographic regions and product innovation. "Celanese has developed a patented process to produce ethanol from hydrocarbon feedstocks, like natural gas. The method is 40% cheaper than producing ethanol from agricultural feedstocks, like corn," he said. Celanese rose more than 2% over the past month to $46.14 in morning trading Monday. -By Amy Or, Dow Jones Newswires; 212-416-3142; amy.or@dowjones.com

Stock News for Cvs (CVS)
DateTimeHeadline
05/13/201309:25:33Walgreen Will Remain in CVS's Pharmacy Benefit Management Unit's...
05/01/201308:40:06CVS Caremark Net Up 23% Amid Stronger Margins
05/01/201307:56:38CVS Caremark 1st-Quarter Net Up 23% Amid Stronger Margins
04/30/201318:08:21STREET MOVES: Guggenheim Partners Adds Five Senior Bankers From...
04/28/201308:21:11MARKET SNAPSHOT: Data To Overtake Earnings As May Looms
04/25/201308:21:03Cardinal, McKesson Renew Distribution Agreements With CVS
04/18/201315:21:10Bitcoin Buzz Draws Western Union, MoneyGram
04/11/201309:11:45CVS Says Spending On Pricier, Complex Drugs To Keep Rising
04/11/201308:40:05Rite Aid Swings to Profit on Accounting Benefit
04/11/201308:02:01Rite Aid Swings to 4th-Quarter Profit on Inventory-Accounting...
04/03/201313:57:27DOJ: CVS to Pay $11 Million to Settle Claims of Bad Record-Keeping
03/29/201316:55:49CVS Names Former J&J CEO Weldon to Board
03/29/201312:02:07Correction to CVS Caremark Compensation Story
03/29/201310:36:14CVS Caremark CEO Merlo's 2012 Pay Jumps 44% to $20.3 Million
03/12/201316:46:33MARKET SNAPSHOT: Stocks End Mostly Lower, But Dow Rises To Record
03/12/201315:08:35MARKET SNAPSHOT: U.S. Stock Indexes Retreat From Record Run
02/14/201308:40:07Cardinal Health to Buy AssuraMed for $2.07 Billion
02/14/201308:23:17Cardinal Health to Buy Medical-Supplies Provider AssuraMed for...
02/08/201315:48:17Correction to Brazil May Be Next Health-Care Frontier for Global...
02/08/201312:56:14Brazil May Be Next Health-Care Frontier for Global Investors

Cvs and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad